Home / Inspections / 1118072

FDA Inspection 1118072 — Baxalta US Inc.

Baxalta US Inc. — FEI 1000519965

The FDA completed an inspection of Baxalta US Inc. on January 17, 2020 in Thousand Oaks, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 17, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Thousand Oaks, CA (United States)

Facility

Other inspections at this facility

  • 1166545 (VAI Thu Apr 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1038757 (VAI Fri Jan 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 972505 (VAI Thu Mar 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 870344 (VAI Fri Feb 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 740011 (VAI Thu Aug 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources